Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : NOVN    crawled date : 2021 - 07 - 28    save search

Novan Announces Last Patient Visit at Week 24 in B-SIMPLE4 Pivotal Phase 3 Trial of SB206 in Patients with Molluscum Contagiosum
Published: 2021-07-28 (Crawled : 12:15) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: 1.49% H: 2.45% C: -1.47%

molluscum phase 3 trial
Gainers vs Losers
75% 25%

Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M twitter stocktwits trandingview |

AGBA | $2.565 105.2% 51.27% 200M twitter stocktwits trandingview |
Finance

MLEC | $2.44 74.29% 42.62% 78M twitter stocktwits trandingview |
n/a

EDBL | News | $6.28 67.02% 40.13% 16M twitter stocktwits trandingview |

ATGL | $2.91 48.81% 32.8% 180K twitter stocktwits trandingview |

ZAPP | $0.2175 47.16% 32.05% 16M twitter stocktwits trandingview |
n/a

ONFO | $0.6075 38.38% 27.74% 7.3M twitter stocktwits trandingview |
n/a

VIVK | $1.48 38.32% 27.7% 530K twitter stocktwits trandingview |
Professional, Scientific, and T...

MNTS | $0.5 35.69% 26.3% 4.8M twitter stocktwits trandingview |

SDIG A | $3.635 35.13% 26.0% 1M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.